Predictive Oncology to Participate in Upcoming San Francisco Conferences
January 02, 2024 07:00 ET
|
Predictive Oncology Inc.
PITTSBURGH, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that Raymond F. Vennare, Chief Executive...
Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
November 14, 2023 07:00 ET
|
Predictive Oncology Inc.
PITTSBURGH, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science driven company leveraging its proprietary artificial intelligence and machine learning capabilities,...
Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital
November 08, 2023 08:12 ET
|
Predictive Oncology Inc.
PITTSBURGH, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, announced today that it has completed a multi-year study...
Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023
November 07, 2023 07:00 ET
|
Predictive Oncology Inc.
PITTSBURGH, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning...
Predictive Oncology Reports Second Quarter 2023 Financial Results and Provides Business Update
August 10, 2023 17:15 ET
|
Predictive Oncology Inc.
PITTSBURGH, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science driven company leveraging its proprietary artificial intelligence and machine learning capabilities,...
Predictive Oncology to Report Second Quarter 2023 Financial Results and Host Conference Call and Webcast on Thursday, August 10, 2023
August 03, 2023 08:00 ET
|
Predictive Oncology Inc.
EAGAN, Minn., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning...
Predictive Oncology Announces Relocation of Corporate Headquarters to Pittsburgh
July 18, 2023 08:00 ET
|
Predictive Oncology Inc.
Surrounded by world renowned universities and medical centers,Predictive Oncology is part of the next generation of Pittsburgh’s innovation ecosystem PITTSBURGH, July 18, 2023 (GLOBE NEWSWIRE) --...
Predictive Oncology Appoints Biopharmaceutical Finance Veteran Mr. Andrew Einhorn to its Business Advisory Board
June 27, 2023 08:00 ET
|
Predictive Oncology Inc.
EAGAN, Minn., June 27, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning...
Predictive Oncology Appoints Dr. Bernard A. Harris, Jr. to its Newly Formed Business Advisory Board
June 20, 2023 08:00 ET
|
Predictive Oncology Inc.
EAGAN, Minn., June 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning...
Predictive Oncology invited to present groundbreaking approach to drug discovery at the 2023 BIO International Convention
May 23, 2023 08:30 ET
|
Predictive Oncology Inc.
EAGAN, Minn., May 23, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology, Inc. (NASDAQ: POAI) announced today that the company’s Chief Business Officer, Pamela Bush, Ph.D., MBA, will present at the...